ConvaTec Group PLC (CTEC) - Total Liabilities
Based on the latest financial reports, ConvaTec Group PLC (CTEC) has total liabilities worth GBX1.96 Billion GBX (≈ $238.51K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is ConvaTec Group PLC growing its equity to track the company's year-over-year net asset growth rate.
ConvaTec Group PLC - Total Liabilities Trend (2009–2024)
This chart illustrates how ConvaTec Group PLC's total liabilities have evolved over time, based on quarterly financial data. See CTEC cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
ConvaTec Group PLC Competitors by Total Liabilities
The table below lists competitors of ConvaTec Group PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Thonburi Medical Centre Public Company Limited
BK:KDH
|
Thailand | ฿197.58 Million |
|
Blue Lagoon Resources Inc
F:7BL
|
Germany | €10.48 Million |
|
Hansol Csn
KO:009180
|
Korea | ₩123.82 Billion |
|
WI Co. Ltd.
KQ:073570
|
Korea | ₩2.15 Billion |
|
Yesil Gayrimenkul Yatirim Ortakligi AS
IS:YGYO
|
Turkey | TL7.54 Billion |
|
CSL Finance Limited
NSE:CSLFINANCE
|
India | Rs8.10 Billion |
|
Ahoku Electronic Co
TW:3002
|
Taiwan | NT$504.39 Million |
|
Top Win International Limited
NASDAQ:SORA
|
USA | $2.30 Million |
Liability Composition Analysis (2009–2024)
This chart breaks down ConvaTec Group PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CTEC market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ConvaTec Group PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ConvaTec Group PLC (2009–2024)
The table below shows the annual total liabilities of ConvaTec Group PLC from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | GBX1.83 Billion ≈ $222.18K |
-9.64% |
| 2023-12-31 | GBX2.02 Billion ≈ $245.90K |
+1.95% |
| 2022-12-31 | GBX1.98 Billion ≈ $241.19K |
+0.16% |
| 2021-12-31 | GBX1.98 Billion ≈ $240.81K |
-5.56% |
| 2020-12-31 | GBX2.10 Billion ≈ $255.00K |
+2.29% |
| 2019-12-31 | GBX2.05 Billion ≈ $249.28K |
+0.27% |
| 2018-12-31 | GBX2.04 Billion ≈ $248.60K |
-10.27% |
| 2017-12-31 | GBX2.28 Billion ≈ $277.06K |
+0.41% |
| 2016-12-31 | GBX2.27 Billion ≈ $275.91K |
-43.45% |
| 2015-12-31 | GBX4.01 Billion ≈ $487.93K |
-34.66% |
| 2014-12-31 | GBX6.14 Billion ≈ $746.74K |
-8.32% |
| 2013-12-31 | GBX6.69 Billion ≈ $814.50K |
+5.39% |
| 2012-12-31 | GBX6.35 Billion ≈ $772.85K |
+10.69% |
| 2011-12-31 | GBX5.74 Billion ≈ $698.20K |
+1.64% |
| 2010-12-31 | GBX5.65 Billion ≈ $686.95K |
-0.55% |
| 2009-12-31 | GBX5.68 Billion ≈ $690.76K |
-- |
About ConvaTec Group PLC
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostom… Read more